Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

September 20, 2020

Study Completion Date

September 20, 2020

Conditions
Endometriosis Related PainOveractive BladderDiabetic Neuropathic PainRefractory or Unexplained Chronic Cough
Interventions
DRUG

BAY1817080

Three different doses over the course of study

DRUG

Matching Placebo

Matching Placebo to BAY1817080

Trial Locations (1)

812-0025

Hakata Clinic, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY